Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 139

1.

Guillain-Barre syndrome during the 2009-2010 H1N1 influenza vaccination campaign: population-based surveillance among 45 million Americans.

Wise ME, Viray M, Sejvar JJ, Lewis P, Baughman AL, Connor W, Danila R, Giambrone GP, Hale C, Hogan BC, Meek JI, Murphree R, Oh JY, Reingold A, Tellman N, Conner SM, Singleton JA, Lu PJ, DeStefano F, Fridkin SK, Vellozzi C, Morgan OW.

Am J Epidemiol. 2012 Jun 1;175(11):1110-9. doi: 10.1093/aje/kws196. Epub 2012 May 11.

2.

Risk of confirmed Guillain-Barre syndrome following receipt of monovalent inactivated influenza A (H1N1) and seasonal influenza vaccines in the Vaccine Safety Datalink Project, 2009-2010.

Greene SK, Rett M, Weintraub ES, Li L, Yin R, Amato AA, Ho DT, Sheikh SI, Fireman BH, Daley MF, Belongia EA, Jacobsen SJ, Baxter R, Lieu TA, Kulldorff M, Vellozzi C, Lee GM.

Am J Epidemiol. 2012 Jun 1;175(11):1100-9. doi: 10.1093/aje/kws195. Epub 2012 May 11.

PMID:
22582210
3.
4.

The risk of Guillain-Barré syndrome associated with influenza A (H1N1) 2009 monovalent vaccine and 2009-2010 seasonal influenza vaccines: results from self-controlled analyses.

Tokars JI, Lewis P, DeStefano F, Wise M, Viray M, Morgan O, Gargiullo P, Vellozzi C.

Pharmacoepidemiol Drug Saf. 2012 May;21(5):546-52. doi: 10.1002/pds.3220. Epub 2012 Mar 8.

PMID:
22407672
5.

Guillain-Barré syndrome and adjuvanted pandemic influenza A (H1N1) 2009 vaccines: a multinational self-controlled case series in Europe.

Romio S, Weibel D, Dieleman JP, Olberg HK, de Vries CS, Sammon C, Andrews N, Svanström H, Mølgaard-Nielsen D, Hviid A, Lapeyre-Mestre M, Sommet A, Saussier C, Castot A, Heijbel H, Arnheim-Dahlström L, Sparen P, Mosseveld M, Schuemie M, van der Maas N, Jacobs BC, Leino T, Kilpi T, Storsaeter J, Johansen K, Kramarz P, Bonhoeffer J, Sturkenboom MC.

PLoS One. 2014 Jan 3;9(1):e82222. doi: 10.1371/journal.pone.0082222. eCollection 2014.

6.

Risk of Guillain-Barré syndrome following H1N1 influenza vaccination in Quebec.

De Wals P, Deceuninck G, Toth E, Boulianne N, Brunet D, Boucher RM, Landry M, De Serres G.

JAMA. 2012 Jul 11;308(2):175-81. doi: 10.1001/jama.2012.7342.

PMID:
22782419
7.

Guillain-Barré syndrome following pandemic (H1N1) 2009 influenza A immunisation in Victoria: a self-controlled case series.

Crawford NW, Cheng A, Andrews N, Charles PG, Clothier HJ, Day B, Day T, Gates P, Macdonell R, Roberts L, Rodriguez-Casero V, Wijeratne T, Kiers L.

Med J Aust. 2012 Nov 19;197(10):574-8. Erratum in: Med J Aust. 2014 Apr 7;200(6):321. Macdonnell, Richard [corrected to Macdonell, Richard].

PMID:
23163689
8.

Chart-confirmed guillain-barre syndrome after 2009 H1N1 influenza vaccination among the Medicare population, 2009-2010.

Polakowski LL, Sandhu SK, Martin DB, Ball R, Macurdy TE, Franks RL, Gibbs JM, Kropp GF, Avagyan A, Kelman JA, Worrall CM, Sun G, Kliman RE, Burwen DR.

Am J Epidemiol. 2013 Sep 15;178(6):962-73. doi: 10.1093/aje/kwt051. Epub 2013 May 6.

PMID:
23652165
9.

International collaboration to assess the risk of Guillain Barré Syndrome following Influenza A (H1N1) 2009 monovalent vaccines.

Dodd CN, Romio SA, Black S, Vellozzi C, Andrews N, Sturkenboom M, Zuber P, Hua W, Bonhoeffer J, Buttery J, Crawford N, Deceuninck G, de Vries C, De Wals P, Gutierrez-Gimeno MV, Heijbel H, Hughes H, Hur K, Hviid A, Kelman J, Kilpi T, Chuang SK, Macartney K, Rett M, Lopez-Callada VR, Salmon D, Gimenez-Sanchez F, Sanz N, Silverman B, Storsaeter J, Thirugnanam U, van der Maas N, Yih K, Zhang T, Izurieta H; Global H1N1 GBS Consortium..

Vaccine. 2013 Sep 13;31(40):4448-58. doi: 10.1016/j.vaccine.2013.06.032. Epub 2013 Jun 14.

PMID:
23770307
10.

Pandemic influenza A vaccination and incidence of Guillain-Barré syndrome in Korea.

Kim C, Rhie S, Suh M, Kang DR, Choi YJ, Bae GR, Choi YC, Jun BY, Lee JS.

Vaccine. 2015 Apr 8;33(15):1815-23. doi: 10.1016/j.vaccine.2015.02.035. Epub 2015 Feb 26.

PMID:
25728315
11.

Guillain-Barré syndrome following the 2009 pandemic monovalent and seasonal trivalent influenza vaccination campaigns in Spain from 2009 to 2011: outcomes from active surveillance by a neurologist network, and records from a country-wide hospital discharge database.

Alcalde-Cabero E, Almazán-Isla J, García López FJ, Ara-Callizo JR, Avellanal F, Casasnovas C, Cemillán C, Cuadrado JI, Duarte J, Fernández-Pérez MD, Fernández Ó, Merino JA, Montero RG, Montero D, Pardo J, Rodríguez-Rivera FJ, Ruiz-Tovar M, de Pedro-Cuesta J; Spanish GBS Epidemiology Study Group..

BMC Neurol. 2016 May 21;16:75. doi: 10.1186/s12883-016-0598-z.

12.

Association between Guillain-Barré syndrome and influenza A (H1N1) 2009 monovalent inactivated vaccines in the USA: a meta-analysis.

Salmon DA, Proschan M, Forshee R, Gargiullo P, Bleser W, Burwen DR, Cunningham F, Garman P, Greene SK, Lee GM, Vellozzi C, Yih WK, Gellin B, Lurie N; H1N1 GBS Meta-Analysis Working Group..

Lancet. 2013 Apr 27;381(9876):1461-8. doi: 10.1016/S0140-6736(12)62189-8. Epub 2013 Mar 13.

PMID:
23498095
13.

Guillain-Barré syndrome and H1N1 (2009) pandemic influenza vaccination using an AS03 adjuvanted vaccine in the United Kingdom: self-controlled case series.

Andrews N, Stowe J, Al-Shahi Salman R, Miller E.

Vaccine. 2011 Oct 19;29(45):7878-82. doi: 10.1016/j.vaccine.2011.08.069. Epub 2011 Aug 27.

PMID:
21875631
14.

Surveillance for adverse events following receipt of pandemic 2009 H1N1 vaccine in the Post-Licensure Rapid Immunization Safety Monitoring (PRISM) System, 2009-2010.

Yih WK, Lee GM, Lieu TA, Ball R, Kulldorff M, Rett M, Wahl PM, McMahill-Walraven CN, Platt R, Salmon DA.

Am J Epidemiol. 2012 Jun 1;175(11):1120-8. doi: 10.1093/aje/kws197. Epub 2012 May 11.

PMID:
22582207
15.

Cumulative risk of Guillain-Barré syndrome among vaccinated and unvaccinated populations during the 2009 H1N1 influenza pandemic.

Vellozzi C, Iqbal S, Stewart B, Tokars J, DeStefano F.

Am J Public Health. 2014 Apr;104(4):696-701. doi: 10.2105/AJPH.2013.301651. Epub 2014 Feb 13.

16.

Guillain-Barré syndrome after H1N1 vaccination in the United States: a report using the CDC/FDA Vaccine Adverse Event Reporting System (2009).

Souayah N, Yacoub HA, Khan HM, Michas-Martin PA, Menkes DL, Maybodi L, Qureshi AI.

Neuroepidemiology. 2012;38(4):227-32. doi: 10.1159/000336113. Epub 2012 Apr 27.

PMID:
22555646
17.

Invited commentary: Influenza vaccine and Guillain-Barre syndrome--is there a risk?

Nelson KE.

Am J Epidemiol. 2012 Jun 1;175(11):1129-32. doi: 10.1093/aje/kws194. Epub 2012 May 11.

PMID:
22582208
18.

Surveillance for Guillain-Barré syndrome after influenza vaccination among the Medicare population, 2009-2010.

Burwen DR, Sandhu SK, MaCurdy TE, Kelman JA, Gibbs JM, Garcia B, Markatou M, Forshee RA, Izurieta HS, Ball R; Safety Surveillance Working Group..

Am J Public Health. 2012 Oct;102(10):1921-7. Epub 2012 Feb 16.

19.

Risk of Guillain-Barré syndrome following pandemic influenza A(H1N1) 2009 vaccination in Germany.

Prestel J, Volkers P, Mentzer D, Lehmann HC, Hartung HP, Keller-Stanislawski B; GBS Study Group..

Pharmacoepidemiol Drug Saf. 2014 Nov;23(11):1192-204. doi: 10.1002/pds.3638. Epub 2014 May 10.

20.

Pandemic A/H1N1 2009 influenza vaccination, preceding infections and clinical findings in UK children with Guillain-Barré syndrome.

Verity C, Stellitano L, Winstone AM, Stowe J, Andrews N, Miller E.

Arch Dis Child. 2014 Jun;99(6):532-8. doi: 10.1136/archdischild-2013-304475. Epub 2014 Feb 28.

PMID:
24585755

Supplemental Content

Support Center